Next revision | Previous revisionBoth sides next revision |
pharmaceutical_companies:astrazeneca [2022/01/13 10:09] liam created | pharmaceutical_companies:astrazeneca [2024/12/18 22:44] (current) liam |
---|
| |
{{ :pharmaceutical_companies:astrazenecalogo.png?200|}} | {{ :pharmaceutical_companies:astrazenecalogo.png?200|}} |
| |
| ===== COVID-19 ===== |
| |
| AstraZeneca is distributing a viral vector-based [[:COVID-19]] vaccine product in Canada and other countries called [[pharmaceutical_products:AstraZeneca ChAdOx1 nCoV-19|ChAdOx1 nCoV-19]]. It is marketed in Canada as Vaxzevria.((Health Canada. (2021, November 23). //AstraZeneca Vaxzevria COVID-19 vaccine.// Government of Canada. Retrieved December 5, 2021, from https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/astrazeneca.html)) |
| |
| ===== Affiliations ===== |
| |
| AstraZeneca was a founding member of the [[:Alliance for a Stronger FDA]].((//AstraZeneca Calls for FDA Funding Increase.// (2010, September 20). Pharmaceutical Technology. https://web.archive.org/web/20220817001606/https://www.pharmaceutical-technology.com/uncategorized/news96475-html/)) |
| |
| AstraZeneca is a member organization of the [[:World Economic Forum]].((//AstraZeneca.// (2021, December 3). World Economic Forum. https://archive.ph/CV1XD)) |
| |
| ==== Acquisitions ==== |
| |
| AstraZeneca acquired [[Alexion]] in 2021, adding its rare disease brand to the company's portfolio.((Kemp, A. (2021, July 21). //Acquisition of Alexion completed.// AstraZeneca. https://archive.ph/c5apv)) |
| |
| ===== Payments from AstraZeneca ===== |
| |
| The following is a developing list of individuals and organizations that [[AstraZeneca]] has given money to related to the [[:COVID-19 pandemic]]: |
| |
| ==== Payments to Individuals ==== |
| |
| ^ Name ^ Type ^ Amount ^ Description ^ |
| | [[:David Fisman]] | Honorarium | Unknown | Honorarium paid for advisory board meetings regarding COVID-19 related projects.((Fisman, D. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2020/10/Declaration-of-Interest_Science-Table_David-Fisman2.pdf)) | |
| | [[:Kyla Hildebrand]] | Research | Unknown | Research funding for allergy study((Chan, E. S., Abrams, E. M., Hildebrand, K. J., & Watson, W. (2018). //Early introduction of foods to prevent food allergy.// Allergy, Asthma & Clinical Immunology, 14(S2). https://doi.org/10.1186/s13223-018-0286-1)) | |
| ==== Payments to Organizations ==== |
| ^ Name ^ Type ^ Amount ^ Description ^ |
| | [[:st._michael_s_hospital_foundation|St. Michaels Hospital Foundation]] | Donation | $1,000,000.00 - $2,499,999.00 | Lifetime donations.((//St. Michael’s Foundation 2020/21 Annual Report.// (2021). FlippingBook. https://online.flippingbook.com/view/383454962/40/)) | |
| | [[:University Hospitals Kingston Foundation]] | Donation | $50,000.00 – $99,999.00 | Cumulative donations up to December 31, 2019.((//Recognizing your contribution.// University Hospitals Kingston Foundation. Retrieved February 21, 2022, from https://www.uhkf.ca/Your-Impact/Recognizing-Your-Contribution)) | |
| |
| ===== External links ===== |
| |
| * [[https://wiki.whiteroseintelligence.com/AstraZeneca|White Rose Wiki]] |